There are 2789 resources available
794P - Comparative study of effectiveness of Pap smear and visual inspection with acetic acid for screening of premalignant and malignant lesion of cervix in a tertiary care setup
Presenter: Meena Kakollu
Session: ePoster Display
796P - Association between biomarkers and clinical outcomes of lenvatinib (L) + pembrolizumab (P) in advanced endometrial cancer (EC): Results from KEYNOTE-146/study 111
Presenter: Vicky Makker
Session: ePoster Display
798P - A phase II study of pembrolizumab (P) in combination with doxorubicin (D) in advanced endometrial cancer (AEC): TOPIC trial/VHIO10001
Presenter: Lorena Fariñas-Madrid
Session: ePoster Display
799P - Anlotinib plus sintilimab in patients with recurrent advanced endometrial cancer: A prospective open-label, single-arm, phase II clinical trial
Presenter: Wei Wei
Session: ePoster Display
800P - Tailoring adjuvant treatments in high-risk early stage endometrial cancer: Clinical outcomes of sequential chemoradiation in a real-word scenario
Presenter: Marco de Scordilli
Session: ePoster Display
801P - Response to first-line platinum chemotherapy in microsatellite instability high (MSI-H) metastatic endometrial carcinoma
Presenter: Emeline Colomba
Session: ePoster Display
802P - A machine learning-based framework for efficacy and safety analysis of PD-1PD-L1 inhibitor application in gynaecological cancer on incomplete post-marketing surveillance dataset
Presenter: xiaomei Liu
Session: ePoster Display
687P - NIVOREN GETUG-AFU 26 translational study: Baseline peripheral cytokines predict survival in metastatic clear cell renal carcinoma (RCC) treated with nivolumab
Presenter: Lucia Carril Ajuria
Session: ePoster Display
688P - Gene expression profiling (GEP) signatures associated with markers of sensitivity to immune and angiogenic therapy in clear-cell renal cell carcinoma (ccRCC) with sarcomatoid/rhabdoid features
Presenter: Pedro Miguel Coelho Barata
Session: ePoster Display